ARIAD to Present at Upcoming Investor Conferences
February 29 2016 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
Paris Panayiotopoulos, president and chief executive officer, will
provide an overview of the Company’s business at two upcoming
investor conferences:
- The Cowen and Company 36th Annual
Health Care Conference being held in Boston on Wednesday, March 9,
at 8:40 a.m. (ET)
- The Barclays Global Healthcare
Conference being held in Miami on Thursday, March 17, at 8:00 a.m.
(ET).
The ARIAD presentations will be webcast live and can be accessed
by visiting the investor relations section of the Company's website
at http://www.ariad.com/investor. Replays of these presentations
will also be available and archived on the site for three
weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in
Cambridge, Massachusetts and Lausanne, Switzerland, is an
integrated global oncology company focused on transforming the
lives of cancer patients with breakthrough medicines. ARIAD is
working on new medicines to advance the treatment of various forms
of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and
structural approaches to design small-molecule drugs that overcome
resistance to existing cancer medicines. For additional
information, visit http://www.ariad.com or follow ARIAD on Twitter
(@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160229005279/en/
ARIAD Pharmaceuticals, Inc.For InvestorsMaria Cantor,
617-621-2208Maria.cantor@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From May 2024 to Jun 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jun 2023 to Jun 2024